心臓血管外科用デバイス市場：製品タイプ、手技タイプ、エンドユーザー別-2025～2030年の世界予測

心臓血管外科用デバイス市場は、2023年に15億7,000万米ドルと評価され、2024年には16億5,000万米ドルに達すると予測され、CAGR 5.43%で成長し、2030年には22億7,000万米ドルに達すると予測されています。

心臓血管外科用デバイス市場には、心血管障害の診断、治療、管理のために設計された機器や装置が幅広く含まれています。この市場には、人工心肺装置、カテーテル、ステント、グラフトなど、冠動脈バイパス移植術（CABG）、心臓弁修復術、心臓弁置換術などの外科手術に不可欠な機器が含まれます。これらの機器の必要性は、人口の高齢化、座りっぱなしのライフスタイル、肥満率の増加によって心血管疾患の発生率が上昇していることに起因しています。これらの機器は、病院、心臓専門治療センター、外来患者施設などで使用され、従来の外科手術と低侵襲外科手術の両方で重要な役割を果たしています。

市場成長は、技術の進歩、低侵襲手術への嗜好の高まり、主要企業による大規模な研究開発投資など、いくつかの要因に影響されます。手術機器にAIやIoTを統合するなどの最近の動向は、リアルタイムのデータ分析や予知結果を提供し、手術の成功率を向上させることで、潜在的な機会を引き出しています。企業は、こうした機会を活用するため、製品のイノベーション、価値に基づくケアモデル、戦略的パートナーシップに注力することが奨励されます。逆に、高額な機器コスト、厳しい規制当局の承認、熟練外科医の不足といった制約が、市場拡大の課題となっています。特に新興市場では、規制遵守のハードルが迅速な製品上市と採用の妨げになる可能性があります。

技術革新と研究の機会は、生体吸収性血管足場、ロボット支援手術、従来の手技とカテーテルベースの手技を組み合わせたハイブリッド型カテ室手術環境などの分野で豊富にあります。手術の精度を高め、回復時間を短縮するソリューションを開発すれば、競争上の優位性を提供できます。さらに、急速な技術シフトとヘルスケア償還政策により、市場の性質は非常にダイナミックです。このような技術革新の道筋に焦点を当て、規制状況に適応することで、企業はこの進化するエコシステムにおいて確固たる地位を築き、効率的な心臓血管外科ソリューションに対する需要の高まりに対応しながら持続的な成長を促進することができます。

市場力学：急速に進化する心臓血管外科用デバイス市場の主要市場インサイトを公開

心臓血管外科用デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 外科的介入の増加につながるライフスタイルや食生活の変化による心血管疾患の罹患率の増加
  • 患者の転帰を改善する心臓血管外科用デバイスの急速な技術進歩とイノベーション
  • 心臓疾患を患いやすい高齢化人口の増加による心臓血管外科手術の需要増加
  • 新興市場におけるヘルスケアインフラの拡大と高度医療施設へのアクセス
• 市場抑制要因
  • 心臓血管外科における高度な処置と材料にかかる高コスト
• 市場機会
  • 手術機器における人工知能と機械学習の統合
  • 技術の進歩や高齢化に伴う低侵襲手術への需要の高まり心臓血管外科用デバイス
• 市場の課題
  • 代替治療や非侵襲的心血管系処置による競合の増加。

ポーターの5つの力：心臓血管外科用デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓血管外科用デバイス市場における外部からの影響の把握

外部マクロ環境要因は、心臓血管外科用デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓血管外科用デバイス市場における競合情勢の把握

心臓血管外科用デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓血管外科用デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓血管外科用デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心臓血管外科用デバイス市場における成功への道筋を描く

心臓血管外科用デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 生活習慣や食生活の変化により心血管疾患の発生率が増加し、外科的介入が増加している
    • 患者の転帰を改善する心臓血管外科用デバイスにおける急速な技術進歩と革新
    • 心臓病になりやすい高齢化人口の増加により、心臓血管外科手術の需要が高まっている
    • 新興市場におけるヘルスケアインフラの拡大と先進医療施設へのアクセス
  • 抑制要因
    • 心臓血管外科手術における高度な手順と材料の高コスト
  • 機会
    • 外科用機器における人工知能と機械学習の統合
    • 技術の進歩と人口の高齢化により、低侵襲心臓血管外科用デバイスの需要が高まっています
  • 課題
    • 代替治療および非侵襲性心血管手術との競合が激化しています。
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心臓血管外科用デバイス市場：製品タイプ別

• 人工心肺装置
  • カニューレ
  • 酸素供給装置
  • 貯水池
• 心臓弁デバイス
  • 人工心臓弁
  • 組織心臓弁
  • 経カテーテル心臓弁
• 灌流ディスポーザブル
  • 血液心停止

第7章 心臓血管外科用デバイス市場手順の種類別

• 心臓血管外科
• 冠動脈バイパス移植術（CABG）

第8章 心臓血管外科用デバイス市場：エンドユーザー別

• 心臓センター
• 病院

第9章 南北アメリカの心臓血管外科用デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心臓血管外科用デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心臓血管外科用デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Abbott Laboratories
• 2. Biotronik SE & Co. KG
• 3. Boston Scientific Corporation
• 4. Canon Medical Systems Corporation
• 5. Edwards Lifesciences Corporation
• 6. Fresenius Medical Care AG & Co. KGaA
• 7. GE HealthCare Technologies Inc.
• 8. Getinge AB
• 9. Johnson & Johnson
• 10. LivaNova PLC
• 11. Maquet Cardiovascular LLC
• 12. Medtronic plc
• 13. MicroPort Scientific Corporation
• 14. Philips Healthcare
• 15. Siemens Healthineers AG
• 16. St. Jude Medical, Inc.
• 17. Stryker Corporation
• 18. Terumo Corporation
• 19. W. L. Gore & Associates, Inc.
• 20. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. CARDIOVASCULAR SURGERY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIOVASCULAR SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIOVASCULAR SURGERY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY BLOOD CARDIOPLEGIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 151. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 188. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 189. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 191. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 192. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 211. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 213. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 215. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 216. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 219. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 221. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 222. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 229. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 247. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 253. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 259. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 265. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 271. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 277. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 278. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiovascular Surgery Devices Market was valued at USD 1.57 billion in 2023, expected to reach USD 1.65 billion in 2024, and is projected to grow at a CAGR of 5.43%, to USD 2.27 billion by 2030.

The cardiovascular surgery devices market encompasses a broad array of instruments and equipment designed for the diagnosis, treatment, and management of cardiovascular disorders. This market includes devices such as heart-lung machines, catheters, stents, and grafts, essential for surgical procedures like coronary artery bypass grafting (CABG), heart valve repair, and replacement. The necessity of these devices stems from the rising incidence of cardiovascular diseases fueled by aging populations, sedentary lifestyles, and increasing obesity rates. These devices find application in hospitals, specialized cardiac care centers, and outpatient facilities, serving a critical role in both conventional and minimally invasive surgical procedures.

Market growth is influenced by several factors, including technological advancements, growing preference for minimally invasive surgery, and extensive R&D investment by key players. Recent trends such as the integration of AI and IoT in surgical devices have unlocked potential opportunities by offering real-time data analytics and predictive outcomes, improving surgery success rates. Companies are encouraged to focus on product innovation, value-based care models, and strategic partnerships to leverage these opportunities. Conversely, limitations such as high device costs, stringent regulatory approvals, and the shortage of skilled surgeons pose challenges to market expansion. Regulatory compliance hurdles, particularly in emerging markets, can hinder swift product launches and adoption.

Opportunities for innovation and research are abundant in areas like bioresorbable vascular scaffolds, robot-assisted surgery, and hybrid cath lab operating environments where traditional and catheter-based procedures are combined. Developing solutions that enhance surgical precision and reduce recovery times can offer a competitive advantage. Additionally, the market nature is highly dynamic due to rapid technological shifts and healthcare reimbursement policies. By focusing on these innovation avenues and adapting to regulatory landscapes, businesses can position themselves strongly in this evolving ecosystem, driving sustained growth while meeting the increasing demand for efficient cardiovascular surgical solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Surgery Devices Market

The Cardiovascular Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
  • Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
  • Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
  • Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
• Market Restraints
  • High Cost for advance procedure and material in cardiovascular surgery
• Market Opportunities
  • Integration of artificial intelligence and machine learning in surgical device
  • Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
• Market Challenges
  • Increased competition from alternative treatments and non-invasive cardiovascular procedures.

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Surgery Devices Market

A detailed market share analysis in the Cardiovascular Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Surgery Devices Market

A strategic analysis of the Cardiovascular Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, GE HealthCare Technologies Inc., Getinge AB, Johnson & Johnson, LivaNova PLC, Maquet Cardiovascular LLC, Medtronic plc, MicroPort Scientific Corporation, Philips Healthcare, Siemens Healthineers AG, St. Jude Medical, Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Cardiopulmonary Bypass Equipment, Heart Valve Devices, and Perfusion Disposables. The Cardiopulmonary Bypass Equipment is further studied across Cannulae, Oxygenators, and Reservoirs. The Heart Valve Devices is further studied across Mechanical Heart Valves, Tissue Heart Valves, and Transcatheter Heart Valves. The Perfusion Disposables is further studied across Blood Cardioplegia.
• Based on Procedure Type, market is studied across Cardiovascular Surgery and Coronary Artery Bypass Grafting (CABG).
• Based on End User, market is studied across Cardiac Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
    • 5.1.1.2. Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
    • 5.1.1.3. Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
    • 5.1.1.4. Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost for advance procedure and material in cardiovascular surgery
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence and machine learning in surgical device
    • 5.1.3.2. Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
  • 5.1.4. Challenges
    • 5.1.4.1. Increased competition from alternative treatments and non-invasive cardiovascular procedures.
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiovascular Surgery Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Cardiopulmonary Bypass Equipment
  • 6.2.1. Cannulae
  • 6.2.2. Oxygenators
  • 6.2.3. Reservoirs
• 6.3. Heart Valve Devices
  • 6.3.1. Mechanical Heart Valves
  • 6.3.2. Tissue Heart Valves
  • 6.3.3. Transcatheter Heart Valves
• 6.4. Perfusion Disposables
  • 6.4.1. Blood Cardioplegia

7. Cardiovascular Surgery Devices Market, by Procedure Type

• 7.1. Introduction
• 7.2. Cardiovascular Surgery
• 7.3. Coronary Artery Bypass Grafting (CABG)

8. Cardiovascular Surgery Devices Market, by End User

• 8.1. Introduction
• 8.2. Cardiac Centers
• 8.3. Hospitals

9. Americas Cardiovascular Surgery Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiovascular Surgery Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Surgery Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Biotronik SE & Co. KG
• 3. Boston Scientific Corporation
• 4. Canon Medical Systems Corporation
• 5. Edwards Lifesciences Corporation
• 6. Fresenius Medical Care AG & Co. KGaA
• 7. GE HealthCare Technologies Inc.
• 8. Getinge AB
• 9. Johnson & Johnson
• 10. LivaNova PLC
• 11. Maquet Cardiovascular LLC
• 12. Medtronic plc
• 13. MicroPort Scientific Corporation
• 14. Philips Healthcare
• 15. Siemens Healthineers AG
• 16. St. Jude Medical, Inc.
• 17. Stryker Corporation
• 18. Terumo Corporation
• 19. W. L. Gore & Associates, Inc.
• 20. Zimmer Biomet Holdings, Inc.